Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Computational Modeling in Pharmacology
• Drug Delivery Systems

Background:

• Predicting in vivo drug performance from in vitro data is crucial for drug development.
• Oral dosage forms require understanding drug absorption influenced by solubility and permeability.
• Existing models may not fully capture the complex interplay of physiological and in vitro parameters.

Purpose of the Study:

• To develop and validate an absorption-disposition model for simulating in vivo performance of oral drugs.
• To assess the impact of varying drug solubility and permeability on pharmacokinetic profiles.
• To compare the predictive accuracy of different in vitro permeation techniques.

Main Methods:

• Development of a physiologically-based absorption-disposition model.
• Generation of in vitro permeability data using Caco-2 cells, 2/4/A1 cells, and hexadecane membranes.
• Validation of the model using 13 drugs with diverse physicochemical properties, comparing predicted vs. experimental AUC and Cmax.

Main Results:

• The absorption-disposition model demonstrated high correlation (>0.96) between predicted and experimental AUC and Cmax values across all permeation methods.
• The 2/4/A1 cell permeation technique yielded the highest accuracy in predicting Cmax and AUC.
• The model accurately predicted in vivo performance for 8 out of 9 drugs, with values within 80-125% of experimental AUC when using 2/4/A1 cell data.

Conclusions:

• The developed absorption-disposition model is a robust tool for predicting the in vivo performance of orally administered drugs.
• In vitro permeability data, particularly from 2/4/A1 cells, significantly enhances the model's predictive accuracy.
• This approach can aid in optimizing oral drug formulation and reducing late-stage development failures.